Physiological stability in an indigenous sleep device: a randomised controlled trial
| Autor: | Barry J Taylor, Sally Baddock, Angeline Tangiora, Raymond Jones, David Tipene-Leach, Aleksandra K. Mącznik, Sheila M. Williams |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Native Hawaiian or Other Pacific Islander law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Heart Rate law 030225 pediatrics Heart rate Humans Medicine Oximetry 030212 general & internal medicine Oxygen saturation (medicine) Cultural Characteristics business.industry Co-sleeping Infant Sudden infant death syndrome Intention to Treat Analysis Oxygen Clinical trial Bassinet Relative risk Infant Care Pediatrics Perinatology and Child Health Female Sleep business Biomarkers Sudden Infant Death New Zealand |
| Zdroj: | Archives of Disease in Childhood. 103:377-382 |
| ISSN: | 1468-2044 0003-9888 |
| DOI: | 10.1136/archdischild-2017-313512 |
| Popis: | ObjectiveTo compare overnight oxygen saturation, heart rate and the thermal environment of infants sleeping in an indigenous sleep device (wahakura) or bassinet to identify potential risks and benefits.DesignRandomised controlled trial.SettingFamily homes in low socio-economic areas in New Zealand.Patients200 mainly Māori mothers and their infants.InterventionsParticipants received a wahakura or bassinet from birth.Main outcome measuresOvernight oximetry, heart rate and temperature at 1 month.ResultsIntention-to-treat analysis for 83 bassinet and 84 wahakura infants showed no significant differences between groups for the mean time oxygen saturation (SpO2) was less than 94% (0.54 min, 95% CI -1.36 to 2.45) or less than 90% (0.22 min, 95% CI -0.56 to 1.00), the mean number of SpO2dips per hour >5% (-0.19, 95% CI -3.07 to 2.69) or >10% (-0.41, 95% CI -1.63 to 0.81), mean heart rate (1.99 beats/min, 95% CI -1.02 to 4.99), or time shin temperature >36°C (risk ratio (RR): 0.63, 95% CI 0.13 to 2.99) or ConclusionsThis indigenous sleep device is at least as safe as the currently recommended bassinet, which supports its use as a sleep environment that offers an alternative way of bed-sharing.Trial registration numberAustralian New Zealand Clinical Trials Registry: ACTRN12610000993099. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|